Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99,018 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Danlou tablets in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multicenter prospective cohort study.
Cai Y, Yang Q, Xi R, Yang F, Gu F, Zhao Y, Guo M, Dong G, Gao Z, Fu C, Wang P, Du J, Zhang D, Duan W, Li L, Shi D, Bai R. Cai Y, et al. Among authors: li l. Front Cardiovasc Med. 2024 Sep 24;11:1420194. doi: 10.3389/fcvm.2024.1420194. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39380631 Free PMC article.
Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial.
Wang PL, Zhang L, Wang SL, Yang QN, Gao ZY, Du JP, Zhang DW, Fu CG, Gu F, Xu H, Li LZ, Wang CL, Shi DZ. Wang PL, et al. Among authors: li lz. Chin J Integr Med. 2017 Oct;23(10):740-746. doi: 10.1007/s11655-016-2608-9. Epub 2016 Oct 24. Chin J Integr Med. 2017. PMID: 27778264 Clinical Trial.
miR-941 as a promising biomarker for acute coronary syndrome.
Bai R, Yang Q, Xi R, Li L, Shi D, Chen K. Bai R, et al. Among authors: li l. BMC Cardiovasc Disord. 2017 Aug 22;17(1):227. doi: 10.1186/s12872-017-0653-8. BMC Cardiovasc Disord. 2017. PMID: 28830367 Free PMC article.
The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort Study.
Bai R, Yang Q, Xi R, Che Q, Zhao Y, Guo M, Dong G, Gao Z, Fu C, Wang P, Gu F, Du J, Zhang D, Duan W, Li L, Shi D. Bai R, et al. Among authors: li l. Phytomedicine. 2023 Jan;109:154554. doi: 10.1016/j.phymed.2022.154554. Epub 2022 Nov 19. Phytomedicine. 2023. PMID: 36610159 Free article. Clinical Trial.
Effectiveness and Safety of Qishen Yiqi Dripping Pill in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: 3-Year Results from a Multicentre Cohort Study.
Bai RN, Gu F, Che QZ, Zhang X, Cai YJ, Xi RX, Zhao Y, Guo M, Dong GJ, Gao ZY, Fu CG, Wang PL, Du JP, Zhang DW, Duan WH, Li LZ, Yang QN, Shi DZ. Bai RN, et al. Chin J Integr Med. 2024 Oct;30(10):877-885. doi: 10.1007/s11655-024-3664-1. Epub 2024 Aug 21. Chin J Integr Med. 2024. PMID: 39172302
Effect of Kuanxiong Aerosol () on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial.
Yang QN, Bai RN, Dong GJ, Ge CJ, Zhou JM, Huang L, He Y, Wang J, Ren AH, Huang ZQ, Zhu GL, Lu S, Xiong SQ, Xian SX, Zhu ZJ, Shi DZ, Lu SZ, Li LZ, Chen KJ. Yang QN, et al. Among authors: li lz. Chin J Integr Med. 2018 May;24(5):336-342. doi: 10.1007/s11655-018-2833-5. Epub 2018 Feb 13. Chin J Integr Med. 2018. PMID: 29435729 Clinical Trial.
99,018 results
You have reached the last available page of results. Please see the User Guide for more information.